Literature DB >> 26945099

The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.

Michael Storcksdieck genannt Bonsmann1, Thomas Niezold1, Drew Hannaman2, Klaus Überla3, Matthias Tenbusch4.   

Abstract

Despite more than three decades of intense research, a prophylactic HIV-1 vaccine remains elusive. Four vaccine modalities have been evaluated in clinical efficacy studies, but only one demonstrated at least modest efficacy, which correlated with polyfunctional antibody responses to the HIV surface protein Env. To be most effective, a HIV-1 vaccine probably has to induce both, functional antibody and CD8(+) T cell responses. We therefore analyzed DNA/DNA and DNA/virus-like particle (VLP) regimens for their ability to induce humoral and cellular immune responses. Here, DNA vaccination of mice induced strong CD8(+) responses against Env and Gag. However, the humoral response to Env was dominated by IgG1, a subclass known for its low functionality. In contrast, priming only with the Gag-encoding plasmid followed by a boost with VLPs consisting of Gag and Env improved the quality of the anti-Env antibody response via intrastructural help (ISH) provided by Gag-specific T cells to Env-specific B cells. Furthermore, the Gag-specific CD8(+) T cells induced by the DNA prime immunization could still protect from a lethal infection with recombinant vaccinia virus encoding HIV Gag. Therefore, this immunization regimen represents a promising approach to combine functional antibody responses toward HIV Env with strong CD8(+) responses controlling early viral replication.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AIDS; Antibodies; CTLs; DNA; HIV-1; VLPs; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 26945099     DOI: 10.1016/j.vaccine.2016.02.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag/Env in outbred CD1 mice.

Authors:  Anne-Marie Carola Andersson; Peter Johannes Holst
Journal:  J Transl Med       Date:  2016-12-20       Impact factor: 5.531

Review 2.  Virus-Like-Vaccines against HIV.

Authors:  Anne-Marie C Andersson; Melanie Schwerdtfeger; Peter J Holst
Journal:  Vaccines (Basel)       Date:  2018-02-11

3.  Computational Design of Epitope-Enriched HIV-1 Gag Antigens with Preserved Structure and Function for Induction of Broad CD8+ T Cell Responses.

Authors:  Benedikt Asbach; Johannes P Meier; Matthias Pfeifer; Josef Köstler; Ralf Wagner
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

4.  Innate signalling molecules as genetic adjuvants do not alter the efficacy of a DNA-based influenza A vaccine.

Authors:  Dennis Lapuente; Viktoria Stab; Michael Storcksdieck Genannt Bonsmann; Andre Maaske; Mario Köster; Han Xiao; Christina Ehrhardt; Matthias Tenbusch
Journal:  PLoS One       Date:  2020-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.